Logo image
Reactivity to heparin in patients with alpha-gal allergy
Journal article   Peer reviewed

Reactivity to heparin in patients with alpha-gal allergy

G. Koo, J. Plager, J.M. Fahrenholz, E. Phillips and C. Stone
Annals of Allergy, Asthma & Immunology, Vol.129(4), pp.515-517
2022
url
Link to Published Version *Subscription may be requiredView

Abstract

Galactose-alpha-1,3-galactose (alpha-gal) syndrome is an immunoglobulin (Ig)E-mediated allergy syndrome to an oligosaccharide found in nonprimate mammalian meat and mammalian-derived products. 1 Oral consumption reactions are characteristically delayed, but are immediate with parenteral administration. 1 Since the discovery of alpha-gal IgE antibodies while investigating hypersensitivity reactions to cetuximab, much attention has been paid to both theoretical risks and reported cases of hypersensitivity reactions to various medications and medical devices derived from nonprimate mammals. 1 ,2 The true extent of this risk is still largely unknown. 3 One medication of interest is heparin; both unfractionated heparin and low-molecular weight heparin, enoxaparin, are derived from porcine intestinal tissue. In a case of immediate hypersensitivity to heparin in a patient with a high concentration of alpha-gal–specific IgE (sIgE), we would like to draw attention to positive skin testing result to heparin products.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.65 Allergy
1.65.264 Allergy Mechanisms
Web Of Science research areas
Allergy
Immunology
ESI research areas
Immunology
Logo image